The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Conditions

• Cancer of Stomach
• Esophageal Neoplasms
• GI Cancer
• GIST
• Gastric Adenocarcinoma
• Gastric Cancer
• Gastric Neoplasm
• Neuroendocrine Tumors
• Oesophageal Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Study Details

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

Key Dates

First listed

Apr 7, 2023

Start date

Mar 14, 2023

Status verified

Mar 2025

Primary completion

Mar 14, 2028

Completion

Sep 14, 2028

Study Design

Enrollment

500 participants (estimated)

Arms

• Arm: Patient with Gastrointestinal neoplasm
  Pt referred for resection of gastrointestinal neoplasm. Observational data collected from endoscopic submucosal dissection (ESD), submucosal-tunnelling endoscopic resection (STER) or endoscopic full-thickness resection (EFTR) of gastrointestinal neoplasm

Primary Outcome Measure

Effectiveness of endoscopic resection of UGI neoplastic lesions: completeness of resection [ Time Frame: 2 weeks ]

Central Contacts

• Michael Bourke
  02 8890 5555
  [email protected]

Find similar trials

Related Studies

• Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
  Recruiting · Vanderbilt University Medical Center · Nashville, Tennessee
• Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
  Enrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
• The Gastric Cancer Foundation: A Gastric Cancer Registry
  Recruiting · Stanford University · Stanford, California
• Integrated Cancer Repository for Cancer Research
  Recruiting · University of Nebraska · Greenwood Village, Colorado